Process for purifying N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide(zaleplon) and crystalline forms of zaleplon accessible with the process
Provided are novel Zaleplon crystalline Forms II, III, IV and V, which are useful for the treatment of insomnia. Also provided are processes for making Forms I, II, and V using precipitation methods.
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | Feher, Erika Korodi, Ferenc Singer, Claude Magyar, Erika |
description | Provided are novel Zaleplon crystalline Forms II, III, IV and V, which are useful for the treatment of insomnia. Also provided are processes for making Forms I, II, and V using precipitation methods. |
format | Patent |
fullrecord | <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_07348429</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>07348429</sourcerecordid><originalsourceid>FETCH-uspatents_grants_073484293</originalsourceid><addsrcrecordid>eNqNjrEKAjEQRK-xEPUftvTABfWU01oUK7GwE5E17nmBNQlJROLf-Kd6qL3VMMyDee3sufVWcQhQWQ_u5nWVtLnABvcF9gtUiYx1ydPDit2PBlOkw7vqqz5rgyUmyV3NJskBN8ixTkKKI71n7j9I2Ik1OZA5g_IpRBLRhpuvawBbwQ8BUo2EPgnDXccaYs3gPmbdrFWRBO59s5PBarlbrPEWHEU2MRwvnpoYlsVkNhnPiz-QF3MtVf0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Process for purifying N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide(zaleplon) and crystalline forms of zaleplon accessible with the process</title><source>USPTO Issued Patents</source><creator>Feher, Erika ; Korodi, Ferenc ; Singer, Claude ; Magyar, Erika</creator><creatorcontrib>Feher, Erika ; Korodi, Ferenc ; Singer, Claude ; Magyar, Erika ; TEVA Gyógyszergyár Zártköruen Muködö Részvénytársaság</creatorcontrib><description>Provided are novel Zaleplon crystalline Forms II, III, IV and V, which are useful for the treatment of insomnia. Also provided are processes for making Forms I, II, and V using precipitation methods.</description><language>eng</language><creationdate>2008</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7348429$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,776,798,881,64012</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7348429$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Feher, Erika</creatorcontrib><creatorcontrib>Korodi, Ferenc</creatorcontrib><creatorcontrib>Singer, Claude</creatorcontrib><creatorcontrib>Magyar, Erika</creatorcontrib><creatorcontrib>TEVA Gyógyszergyár Zártköruen Muködö Részvénytársaság</creatorcontrib><title>Process for purifying N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide(zaleplon) and crystalline forms of zaleplon accessible with the process</title><description>Provided are novel Zaleplon crystalline Forms II, III, IV and V, which are useful for the treatment of insomnia. Also provided are processes for making Forms I, II, and V using precipitation methods.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2008</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNqNjrEKAjEQRK-xEPUftvTABfWU01oUK7GwE5E17nmBNQlJROLf-Kd6qL3VMMyDee3sufVWcQhQWQ_u5nWVtLnABvcF9gtUiYx1ydPDit2PBlOkw7vqqz5rgyUmyV3NJskBN8ixTkKKI71n7j9I2Ik1OZA5g_IpRBLRhpuvawBbwQ8BUo2EPgnDXccaYs3gPmbdrFWRBO59s5PBarlbrPEWHEU2MRwvnpoYlsVkNhnPiz-QF3MtVf0</recordid><startdate>20080325</startdate><enddate>20080325</enddate><creator>Feher, Erika</creator><creator>Korodi, Ferenc</creator><creator>Singer, Claude</creator><creator>Magyar, Erika</creator><scope>EFH</scope></search><sort><creationdate>20080325</creationdate><title>Process for purifying N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide(zaleplon) and crystalline forms of zaleplon accessible with the process</title><author>Feher, Erika ; Korodi, Ferenc ; Singer, Claude ; Magyar, Erika</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_073484293</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2008</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Feher, Erika</creatorcontrib><creatorcontrib>Korodi, Ferenc</creatorcontrib><creatorcontrib>Singer, Claude</creatorcontrib><creatorcontrib>Magyar, Erika</creatorcontrib><creatorcontrib>TEVA Gyógyszergyár Zártköruen Muködö Részvénytársaság</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Feher, Erika</au><au>Korodi, Ferenc</au><au>Singer, Claude</au><au>Magyar, Erika</au><aucorp>TEVA Gyógyszergyár Zártköruen Muködö Részvénytársaság</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Process for purifying N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide(zaleplon) and crystalline forms of zaleplon accessible with the process</title><date>2008-03-25</date><risdate>2008</risdate><abstract>Provided are novel Zaleplon crystalline Forms II, III, IV and V, which are useful for the treatment of insomnia. Also provided are processes for making Forms I, II, and V using precipitation methods.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_uspatents_grants_07348429 |
source | USPTO Issued Patents |
title | Process for purifying N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide(zaleplon) and crystalline forms of zaleplon accessible with the process |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T19%3A53%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Feher,%20Erika&rft.aucorp=TEVA%20Gy%C3%B3gyszergy%C3%A1r%20Z%C3%A1rtk%C3%B6ruen%20Muk%C3%B6d%C3%B6%20R%C3%A9szv%C3%A9nyt%C3%A1rsas%C3%A1g&rft.date=2008-03-25&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E07348429%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |